Infectocef Saft

Cefaclor, the active ingredient in Infectocef Saft, is a second‑generation cephalosporin presented as an oral suspension for oral use. It treats bacterial infections such as acute otitis media, pharyngitis, sinusitis, bronchitis and urinary tract infections in children and adults, and is indicated for use in both pediatric and adult populations.

GNH USA supplies Infectocef Saft as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is distributed to healthcare providers across multiple regions.

Cefaclor is a second‑generation cephalosporin antibiotic that targets bacterial infections of the respiratory and urinary tracts.

Acute otitis media: resolves middle‑ear infection caused by susceptible bacteria. Pharyngitis / tonsillitis: reduces bacterial load and alleviates throat symptoms. Sinusitis: treats acute bacterial sinus infection. Bronchitis: helps clear bacterial bronchial infection. Urinary tract infections: clears susceptible uropathogens.

Cefaclor may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Diarrhea: loose stools occurring during treatment. - Nausea: feeling of unease or urge to vomit. - Vomiting: expulsion of stomach contents. - Rash: mild skin redness or itching.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening allergic reaction. - Clostridioides difficile‑associated colitis: severe inflammation of the colon. - Stevens‑Johnson syndrome: rare, serious skin and mucous membrane disorder.

When prescribing or dispensing Cefaclor, consider the following precautions to ensure safe use.

Allergy assessment: verify no known hypersensitivity to cephalosporins or penicillins. Renal function monitoring: adjust dosing in patients with impaired kidney function. Gastrointestinal disease: use cautiously in patients with a history of colitis. Neonatal use: avoid in neonates for certain infections unless specifically indicated. Pregnancy and lactation: discuss risk‑benefit with the prescriber before use. Store at below 25°C: keep in the original container, protect from moisture and light.

Cefaclor can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Probenecid: reduces renal excretion of cefaclor, increasing plasma levels. - Aminoglycosides: combined use may increase risk of nephrotoxicity. - Warfarin: potential for increased anticoagulant effect and INR.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in contraceptive effectiveness. - Antacids containing aluminum or magnesium: may decrease cefaclor absorption. - Loop diuretics: monitor electrolytes as cefaclor can affect renal handling.